Healthcare & Life Sciences
Eyebiotech Limited
United Kingdom
acquiredacquired
acquired
Stage
About
Eyebiotech Limited is a clinical-stage ophthalmology biotechnology company developing next-generation therapies for diseases affecting the back of the eye. The company was acquired by Merck in 2024.
Explore Eyebiotech Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.